s6y
Company name or ticker
Search
Rozenman Mary M.
4
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
Filed
Friday, November 4, 2016
Period
Nov 4, 2016
Accession number
0000899243-16-032770
Documents
FORM 4 SUBMISSION
4
On sec.gov
Filing index
All files
Complete submission text
SGML header